Microfluidic Devices Market Growth, Demand & Opportunities

1. Increasing Research in Genomics To Augment Microfluidic Devices Sale 1 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

2. The National Human Genome Research Institute (NHGRI) works toward improving human health and increasing research in the field of genomics. The institute supports research in genomics through its Computational Genomics and Data Science Program, Genome Sequencing Program, Population Architecture Using Genomics and Epidemiology (PAGE) Consortium), and the Alliance of Genome Resources (Alliance) Consortium. Likewise, the European Union (EU) facilitates research in the field of genomics through the European Advanced infraStructure for Innovative Genomics (EASI) initiative, which is an essential part of its Horizon 2020 program. Thus, the increasing research in genomics is expected to supplement the microfluidic devices market growth in the next few years. Moreover, the burgeoning demand for point-of-care testing products, owing to the rising incidence of lifestyle-associated diseases, will also attribute to the market growth in the foreseeable future. For instance, the International Diabetes Federation (IDF) states that 643 million adults aged 20–79 years will be living with diabetes by 2030, and this number will rise to 783 million by 2045. At present, the highest number of microfluidic devices are used in pharmaceutical and life science research, due to the rising burden of genetic diseases and mounting healthcare expenditure. Additionally, these devices are also used in clinical and veterinary diagnostics, point-of-care diagnostics, analytical devices, environmental and industrial, and drug delivery applications. In the upcoming years, a considerable volume of microfluidic devices will be used for point-of-care testing, due to the low cost, portability, and rapid and precise response exhibited by such medical products. The industry segment of the microfluidic devices market is classified into medical devices, in-vitro diagnostics (IVD), pharmaceuticals, and others. Under this segment, the IVD category is expected to generate the highest revenue in the foreseeable future. Whereas, the medical devices category is projected to witness the fastest growth in the forthcoming years, owing to the increasing incidence of surgical procedures. For example, the European Union (EU) states that at least 1.6 million cesarean sections (C-sections) were performed in member states in 2018. To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/microfluidic-devices- market/report-sample Access Detailed Report - Microfluidic Devices Market Growth Factors, and Trends In contemporary years, these industries use microfluid devices manufactured by Agilent Technologies Inc., Dolomite Microfluidics, RainDance Technologies Inc., Bio-Rad Laboratories Inc., Johnson & Johnson, Abbott Laboratories, F. Hoffmann-La Roche AG, Cepheid Inc., Micronit Microfluidics, Becton, Dickinson 2 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

3. and Company, Fluidigm Corporation, and Siemens AG. These companies use glass, silicon, and polymer in their microfluidic devices. In the coming years, these companies will utilize a considerable volume of polymer in their offerings because of its low cost, optical transparency, non-toxicity, oxygen permeability, and gas permeability. According to P&S Intelligence, North America will account for the largest share in the microfluidic devices market in the upcoming years, due to the surging geriatric population, growing prevalence of lifestyle-associated diseases such as diabetes, and mounting healthcare expenditure in the region. For instance, the 2019 Diabetes Canada Cost Model states that 1 in 3 Canadians is living with diabetes or prediabetes. Further, the National Diabetes Statistics Report 2020, by the Centers for Disease Control and Prevention (CDC) reveals that over 1 in 10 Americans have diabetes. Thus, the surging research in the field of genomics and the booming demand for point-of-care testing products will create an enormous requirement for microfluidic devices in near future. GLOBAL MARKET BREAKDOWN By industry – global market size of In-vitro diagnostics, Pharmaceuticals, Medical devices and Others By application – global market size of Clinical and veterinary diagnostics, Pharmaceutical and life science research, Point of care diagnostics, Analytical Devices, Drug Delivery, Environmental and industrial, and Others By material – global market size of Polymer, Glass, Silicon and Others By region – global market size of North America, Europe, Asia-Pacific and Rest of the World Market Breakdown by Industry In-vitro diagnostics (IVD) market – breakdown by region Pharmaceutical market – breakdown by region and by product • • • • • • oChips for lab analytics microfluidic devices market share by product Medical devices market – breakdown by region and by product Market Breakdown by Application Point of care testing (POCT) market – breakdown by region Pharmaceutical and life science research market – breakdown by region Drug delivery market – breakdown by region Analytical devices market – breakdown by region Clinical and veterinary diagnostics market – breakdown by region • • • • • • 3 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

4. Environment and industrial market – breakdown by region Market Breakdown by Material Glass market – breakdown by region Polymer market – breakdown by region Silicon market – breakdown by region GLOBAL MARKET BREAKDOWN BY GEOGRAPHY North America – market size of the U.S., Canada and rest of North America Europe – market size of Germany, France, Italy, Spain, the U.K., Belgium, Netherland, Switzerland and rest of Europe Asia-Pacific – market size of Japan, China, India and rest of Asia-Pacific • • • • • • • 4 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

5. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 5 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved